In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: A case report

BMC Urology

Volumn 10, Issue , 2010, Pages

  Zuiverloon, Tahlita Cm ^a   Abas, Cheno S ^a   Van Der Keur, Kirstin A ^a   Vermeij, Marcel ^a   Tjin, Stephen S ^a   Van Tilborg, Angela G ^a   Busstra, Martijn ^a   Zwarthoff, Ellen C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; EPIRUBICIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MITOMYCIN C; PROTEIN P53; FGFR3 PROTEIN, HUMAN;

ADJUVANT THERAPY; ADULT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME LOSS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DRUG SUBSTITUTION; GENE FREQUENCY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEMATURIA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MALE; MICROSATELLITE MARKER; MOLECULAR GENETICS; MULTIPLE CANCER; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIMARY TUMOR; QUALITY OF LIFE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSURETHRAL RESECTION; URINALYSIS; BLADDER TUMOR; GENETIC PREDISPOSITION; GENETICS;

ADULT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; URINARY BLADDER NEOPLASMS;

EID: 77949350039     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-10-5     Document Type: Article

References (21)

1. Bladder carcinoma in patients age 40 years or younger. J Wan HB Grossman, Cancer 1989 64 1 178 181
2. Transitional cell carcinoma of bladder in patients under thirty years of age. JP McCarthy GJ Gavrell GA LeBlanc, Urology 1979 13 5 487 489
3. Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. M Migaldi G Rossi A Maiorana G Sartori P Ferrari C De Gaetani A Cittadini GP Trentini A Sgambato, BJU Int 2004 94 3 311 316
4. Transitional cell carcinoma of the bladder in patients under 40 years of age. A Erozenci S Ataus A Pekyalcin A Kural Z Talat V Solok, Int Urol Nephrol 1994 26 2 179 182
5. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. O Yossepowitch G Dalbagni, J Urol 2002 168 1 61 66
6. Neoplasms of transitional cell origin in first twenty years of life. EJ McGuire RM Weiss AM Baskin, Urology 1973 1 1 57 59
7. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger. PJ Wild J Giedl R Stoehr K Junker S Boehm JM van Oers EC Zwarthoff H Blaszyk SW Fine PA Humphrey, et al. J Pathol 2007 211 1 18 25
8. Sexual function of patients under surveillance for bladder cancer. MN van der Aa MD Bekker TH van der Kwast ML Essink-Bot EW Steyerberg EC Zwarthoff FE Sen HW Elzevier, BJU Int 2009 104 1 35 40
9. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. S Hernandez E Lopez-Knowles J Lloreta M Kogevinas A Amoros A Tardon A Carrato C Serra N Malats FX Real, J Clin Oncol 2006 24 22 3664 3671
10. A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine. JM van Oers I Lurkin AJ van Exsel Y Nijsen BW van Rhijn MN van der Aa EC Zwarthoff, Clin Cancer Res 2005 11 21 7743 7748
11. Microsatellite Analysis of Voided-Urine Samples for Surveillence of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB]). MN van der Aa EC Zwarthoff EW Steyerberg MW Boogaard Y Nijsen KA van der Keur AJ van Exsel WJ Kirkels C Bangma TH van der Kwast, Eur Urol 2008 55 3 659 67
12. Carcinoma of the bladder in patients less than 40 years old. DE Johnson S Hillis, J Urol 1978 120 2 172 173 671625
13. Transitional cell carcinoma of the bladder in patients under 40 years of age. I Ozbey Y Aksoy O Bicgi O Polat G Okyar, Int Urol Nephrol 1999 31 5 655 659
14. A meta-analysis of bladder cancer and diesel exhaust exposure. P Boffetta DT Silverman, Epidemiology 2001 12 1 125 130
15. Radiation-induced leukemia: lessons from history. SC Finch, Best Pract Res Clin Haematol 2007 20 1 109 118
16. Depleted uranium and cancer in Danish Balkan veterans deployed 1992-2001. HH Storm HO Jorgensen AM Kejs G Engholm, Eur J Cancer 2006 42 14 2355 2358
17. Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium. AC Miller C Bonait-Pellie RF Merlot J Michel M Stewart PD Lison, Mol Cell Biochem 2005 279 1-2 97 104
18. Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation. AC Miller K Brooks M Stewart B Anderson L Shi D McClain N Page, J Environ Radioact 2003 64 2-3 247 259
19. Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison. MN van der Aa EW Steyerberg EF Sen EC Zwarthoff WJ Kirkels TH van der Kwast ML Essink-Bot, BJU Int 2008 101 9 1106 1110
20. Comparison of screening methods in the detection of bladder cancer. S Ramakumar J Bhuiyan JA Besse SG Roberts PC Wollan ML Blute DJ O'Kane, J Urol 1999 161 2 388 394
21. Urine markers for bladder cancer surveillance: a systematic review. BW van Rhijn HG van der Poel TH van der Kwast, Eur Urol 2005 47 6 736 748